Form 4: Chemours CEO Denise Dignam Reports Stock Transaction
SEC Form 4 Filing
Chemours CEO Denise Dignam reports a transaction involving common stock to cover tax obligations on vesting restricted stock units and dividend equivalent units.
Summary
- On March 1, 2025, Chemours CEO Denise Dignam reported a transaction involving the withholding of 4,818 common stock shares to satisfy tax obligations.
- The shares were withheld at a price of $14.95 per share.
- Following the transaction, Dignam beneficially owns 70,790.2033 shares, including directly owned shares, restricted stock units, and dividend equivalent units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions for tax purposes, and does not indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's stock activity related to compensation and tax obligations, which is typical for executives.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of the stock transaction (withholding of shares). |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.